{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:53:40Z","timestamp":1793642020316,"version":"4.5.1"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118371","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T05:50:38Z","timestamp":1763272238000},"page":"118371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"P2","title":["Natural alkaloids with therapeutic potential against Alzheimer's disease through cholinesterase inhibition"],"prefix":"10.1016","volume":"302","author":[{"given":"Umam","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moazzam","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Tuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raabia","family":"Naaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayeqa","family":"Qayum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnaaz","family":"Khatoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sanobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakir","family":"Ahamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Saquib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2915-8106","authenticated-orcid":false,"given":"Mohd Kamil","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118371_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117401","article-title":"Phytomolecules as Alzheimer's therapeutics: a comprehensive review","volume":"288","author":"Hussain","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib2","article-title":"A review of butyrylcholinesterase as a therapeutic target in the treatment of alzheimer's disease","volume":"15","author":"Nordberg","year":"2013","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.ejmech.2025.118371_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115249","article-title":"A central role for acetylcholine in entorhinal cortex function and dysfunction with age in humans and mice","volume":"44","author":"Ananth","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.118371_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejmech.2025.118371_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118071","article-title":"Discovery of a highly selective BChE inhibitor with concomitant anti-neuroinflammatory activity for treating Alzheimer's disease","volume":"299","author":"Zhao","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105993","article-title":"Discovery of carbamate-based N-salicyloyl tryptamine derivatives as novel pleiotropic agents for the treatment of Alzheimer's disease","volume":"127","author":"Wang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114044","article-title":"Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib8","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118371_bib9","doi-asserted-by":"crossref","DOI":"10.5493\/wjem.v14.i1.87202","article-title":"Emerging significance of butyrylcholinesterase","volume":"14","author":"Sridhar","year":"2024","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.ejmech.2025.118371_bib10","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41598-018-19701-7","article-title":"Butyrylcholinesterase and acetylcholinesterase polymorphisms in multiple sclerosis patients: implication in peripheral inflammation","volume":"8","author":"Reale","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118371_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14814","article-title":"The selective butyrylcholinesterase inhibitor UW\u2010MD\u201095 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease","volume":"30","author":"Carles","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2025.118371_bib12","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1038\/s41598-019-41578-3","article-title":"Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease","volume":"9","author":"Jasiecki","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118371_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s004390000277","article-title":"Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease","volume":"106","author":"Lehmann","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejmech.2025.118371_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.118371_bib15","author":"Khan"},{"key":"10.1016\/j.ejmech.2025.118371_bib16","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2024.0125-1","article-title":"Excitotoxicity, oxytosis\/Ferroptosis, and neurodegeneration: emerging insights into mitochondrial mechanisms","author":"Khan","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.ejmech.2025.118371_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102735","article-title":"Microglial NOX2 as a therapeutic target in traumatic brain injury: mechanisms, consequences, and potential for neuroprotection","author":"Bano","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118371_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/acschemneuro.4c00617","article-title":"Microglial autophagic dysregulation in traumatic brain injury: molecular insights and therapeutic avenues","volume":"16","author":"Bano","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118371_bib19","doi-asserted-by":"crossref","first-page":"15993","DOI":"10.1021\/acs.jmedchem.2c00799","article-title":"The emerging landscape of small-molecule therapeutics for the treatment of huntington's disease","volume":"65","author":"Ahamad","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2024.216206","article-title":"Advances in nanotherapeutic strategies for Huntington's disease: design, delivery, and neuroprotective mechanisms","volume":"522","author":"Khan","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.118371_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102515","article-title":"Microglia and gut microbiota: a double-edged sword in Alzheimer's disease","volume":"101","author":"Bano","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118371_bib22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2174\/1570159X21666230216104621","article-title":"The emerging landscape of natural small-molecule therapeutics for huntington's disease","volume":"21","author":"Bhat","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2025.118371_bib23","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2174\/15680266113139990142","article-title":"Natural products as sources of new lead compounds for the treatment of alzheimer's disease","volume":"13","author":"Huang","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuint.2015.07.018","article-title":"Plant alkaloids as drug leads for Alzheimer's disease","volume":"89","author":"Ng","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2025.118371_bib25","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib26","article-title":"Naturally occurring acetylcholinesterase inhibitors and their potential use for alzheimer's disease therapy","volume":"9","author":"dos Santos","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118371_bib27","series-title":"Nat. Occur. Chem. Against Alzheimer's Dis.","first-page":"83","article-title":"Galantamine","author":"Rathi","year":"2021"},{"key":"10.1016\/j.ejmech.2025.118371_bib28","first-page":"1","article-title":"Anticholinesterase activity of eight medicinal plant species: in vitro and in silico studies in the search for therapeutic agents against alzheimer's disease, evidence-based complement","volume":"2021","author":"Uddin","year":"2021","journal-title":"Altern. Med."},{"key":"10.1016\/j.ejmech.2025.118371_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/2050312120973499","article-title":"Kinetics and computational analysis of cholinesterase inhibition by REVERC3, a bisdemethoxycurcumin-rich Curcuma longa extract: relevance to the treatment of Alzheimer's disease","volume":"8","author":"Hv","year":"2020","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.ejmech.2025.118371_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2004.11.042","article-title":"Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits","volume":"1033","author":"Geerts","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2025.118371_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0028-3908(91)90005-V","article-title":"Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice","volume":"30","author":"Bickel","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.118371_bib32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2165\/00003495-200060050-00008","article-title":"Galantamine","volume":"60","author":"Scott","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.118371_bib33","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4103\/1673-5374.208572","article-title":"Galantamine protects against beta amyloid peptide-induced DNA damage in a model for Alzheimer's disease","volume":"12","author":"Castillo","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2025.118371_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416182","article-title":"Huperzine\u2014A improved animal behavior in cuprizone-induced mouse model by alleviating demyelination and neuroinflammation","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118371_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202100127","article-title":"Structural fractal analysis of the active site of acetylcholinesterase in complexes with huperzine A, galantamine, and donepezil","volume":"40","author":"Grigorev","year":"2021","journal-title":"Mol. Inform."},{"key":"10.1016\/j.ejmech.2025.118371_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s43088-025-00675-1","article-title":"Huperzine A: a natural acetylcholinesterase inhibitor with multifunctional neuroprotective effects","volume":"14","author":"Suvaiv","year":"2025","journal-title":"Beni-Suef Univ. J. Basic Appl. Sci."},{"key":"10.1016\/j.ejmech.2025.118371_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neulet.2004.01.055","article-title":"Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-\u03b1 in intracerebroventricular \u03b2-amyloid-(1\u201340) infused rats and human embryonic kidney 293 Swedish mutant cells","volume":"360","author":"Zhang","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2025.118371_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phanu.2020.100203","article-title":"Protective effects of Huperzia serrata and its components against oxidative damage and cognitive dysfunction","volume":"13","author":"Ohba","year":"2020","journal-title":"PharmaNutrition"},{"key":"10.1016\/j.ejmech.2025.118371_bib39","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s11011-017-0075-4","article-title":"Huperzine A alleviates neuroinflammation, oxidative stress and improves cognitive function after repetitive traumatic brain injury","volume":"32","author":"Mei","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejmech.2025.118371_bib40","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/aps.2016.78","article-title":"Acetylcholinesterase-independent protective effects of huperzine A against iron overload-induced oxidative damage and aberrant iron metabolism signaling in rat cortical neurons","volume":"37","author":"Tao","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.118371_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000085387","article-title":"Neuroprotective effects of huperzine A","volume":"14","author":"Wang","year":"2005","journal-title":"Neurosignals"},{"key":"10.1016\/j.ejmech.2025.118371_bib42","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.freeradbiomed.2009.02.028","article-title":"Huperzine A protects isolated rat brain mitochondria against \u03b2-amyloid peptide","volume":"46","author":"Gao","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.118371_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neurobiolaging.2019.05.016","article-title":"ABAD\/17\u03b2-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP\/PS1 mice","volume":"81","author":"Xiao","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2025.118371_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00216","article-title":"Huperzine A: is it an effective disease-modifying drug for alzheimers disease?","volume":"6","author":"Qian","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2025.118371_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1745-7254.2005.00130.x","article-title":"Effects of huperzine A on secretion of nerve growth factor in cultured rat cortical astrocytes and neurite outgrowth in rat PC12 cells","volume":"26","author":"Tang","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.118371_bib46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tips.2006.10.004","article-title":"Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease","volume":"27","author":"Zhang","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.118371_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.expneurol.2012.03.024","article-title":"Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice","volume":"236","author":"Wang","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2025.118371_bib48","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.3390\/molecules26216531","article-title":"Huperzine A and its neuroprotective molecular signaling in alzheimer's disease","volume":"26","author":"Friedli","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118371_bib49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1527-3458.1999.tb00105.x","article-title":"Pharmacological profile of huperzine A, a novel acetylcholinesterase inhibitor from Chinese herb","volume":"5","author":"Tang","year":"1999","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejmech.2025.118371_bib50","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1080\/09168451.2015.1052773","article-title":"Japanese Huperzia serrata extract and the constituent, huperzine A, ameliorate the scopolamine-induced cognitive impairment in mice","volume":"79","author":"Ohba","year":"2015","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ejmech.2025.118371_bib51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jnr.22775","article-title":"Huperzine a alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe\/PS1dE9 transgenic mice","volume":"90","author":"Wang","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejmech.2025.118371_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315238","article-title":"Disease-modifying activity of huperzine A on alzheimer's disease: evidence from preclinical studies on rodent models","volume":"23","author":"Yan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118371_bib53","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1212\/WNL.0b013e318216eb7b","article-title":"A phase II trial of huperzine A in mild to moderate alzheimer disease","volume":"76","author":"Rafii","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2025.118371_bib54","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/S0024-3205(02)02034-9","article-title":"Acetylcholinesterase inhibitory activity of some amaryllidaceae alkaloids and narcissus extracts","volume":"71","author":"L\u00f3pez","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.118371_bib55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12031-014-0288-5","article-title":"Synergistic inhibition on acetylcholinesterase by the combination of berberine and palmatine originally isolated from Chinese medicinal herbs","volume":"53","author":"Mak","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118371_bib56","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.bbrc.2005.05.068","article-title":"Juliflorine: a potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer's disease therapy","volume":"332","author":"Choudhary","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.118371_bib57","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1016\/j.bmc.2008.05.027","article-title":"Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge petrosia n. sp","volume":"16","author":"Nukoolkarn","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-1999-13983","article-title":"Protopine from Corydalis ternata has anticholinesterase and antiamnesic activities","volume":"65","author":"Kim","year":"1999","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2025.118371_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153887","article-title":"Protopine promotes the proteasomal degradation of pathological tau in Alzheimer's disease models via HDAC6 inhibition","volume":"96","author":"Sreenivasmurthy","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.118371_bib60","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1021\/np500412f","article-title":"Biotransformation of huperzine A by a fungal Endophyte of Huperzia serrata furnished sesquiterpenoid\u2013alkaloid hybrids","volume":"77","author":"Ying","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118371_bib61","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1021\/np100494u","article-title":"Triterpenoidal alkaloids from Buxus natalensis and their acetylcholinesterase inhibitory activity","volume":"73","author":"Matochko","year":"2010","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118371_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103722","article-title":"Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and A\u03b21-42 aggregation","volume":"98","author":"Plazas","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib63","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1021\/np401003p","article-title":"Chemical composition of the bark of Tetrapterys mucronata and identification of acetylcholinesterase inhibitory constituents","volume":"77","author":"Queiroz","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118371_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154714","article-title":"Magnoflorine improves cognitive deficits and pathology of Alzheimer's disease via inhibiting of JNK signaling pathway","volume":"112","author":"Zhong","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.118371_bib65","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3390\/molecules29051048","article-title":"In vitro and in silico of cholinesterases inhibition and in vitro and in vivo anti-melanoma activity investigations of extracts obtained from selected berberis species","volume":"29","author":"Tuzimski","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118371_bib66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/brainsci11020184","article-title":"Anti-cholinesterase combination drug therapy as a potential treatment for alzheimer's disease","volume":"11","author":"Amat-ur-Rasool","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejmech.2025.118371_bib67","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3390\/cells10051161","article-title":"Berberine improves cognitive impairment by simultaneously impacting cerebral blood flow and \u03b2-Amyloid accumulation in an APP\/tau\/PS1 mouse model of alzheimer's disease","volume":"10","author":"Ye","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.118371_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.exger.2017.02.004","article-title":"Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of \u03b2-amyloid in APP\/tau\/PS1 mouse model of Alzheimer's disease","volume":"91","author":"Huang","year":"2017","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ejmech.2025.118371_bib69","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.bbrc.2017.06.142","article-title":"The effects of berberine on a murine model of multiple sclerosis and the SPHK1\/S1P signaling pathway","volume":"490","author":"Luo","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.118371_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13020-023-00746-4","article-title":"Berberine improves negative symptoms and cognitive function in patients with chronic schizophrenia via anti-inflammatory effect: a randomized clinical trial","volume":"18","author":"Pu","year":"2023","journal-title":"Chin. Med."},{"key":"10.1016\/j.ejmech.2025.118371_bib71","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/acs.jnatprod.5b00191","article-title":"In vitro inhibitory effects of 8- O -Demethylmaritidine and undulatine on acetylcholinesterase and their predicted penetration across the blood\u2013brain barrier","volume":"78","author":"Cahl\u00edkov\u00e1","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118371_bib72","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1021\/acs.jnatprod.9b00490","article-title":"Glucoconjugated monoterpene indole alkaloids from Uncaria rhynchophylla","volume":"82","author":"Guo","year":"2019","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118371_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2020.112459","article-title":"Diterpenoid alkaloids from Aconitum anthoroideum that offer protection against MPP+\u2013induced apoptosis of SH\u2013SY5Y cells and acetylcholinesterase inhibitory activity","volume":"178","author":"Huang","year":"2020","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib74","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.phytochem.2019.03.015","article-title":"Lycofargesiines A\u2013F, further lycopodium alkaloids from the club moss Huperzia fargesii","volume":"162","author":"Xiong","year":"2019","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2021.113017","article-title":"Monoterpene indole alkaloids from Vinca minor L. (apocynaceae): identification of new structural scaffold for treatment of Alzheimer's disease","volume":"194","author":"Vrabec","year":"2022","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib76","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/acs.jnatprod.3c00493","article-title":"Ormosianines A\u2013P, structurally diverse quinolizidine alkaloids with AChE inhibitory effects from Ormosia yunnanensis","volume":"86","author":"Jin","year":"2023","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118371_bib77","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1021\/np4003355","article-title":"Casuarinines A\u2013J, Lycodine-Type alkaloids from Lycopodiastrum casuarinoides","volume":"76","author":"Tang","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118371_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2019.112055","article-title":"Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch master as potential drugs in treatment of Alzheimer's disease","volume":"165","author":"Hulcov\u00e1","year":"2019","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2024.114114","article-title":"Lycopodium alkaloids from Huperzia serrata and their cholinesterase inhibitory activities","volume":"223","author":"Jiang","year":"2024","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib80","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.phymed.2012.12.016","article-title":"3\u2032-R\/S-Hydroxyvoacamine, a potent acetylcholinesterase inhibitor from Tabernaemontana divaricata","volume":"20","author":"Chaiyana","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.118371_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phymed.2014.11.003","article-title":"Natural indole butyrylcholinesterase inhibitors from Nauclea officinalis","volume":"22","author":"Liew","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.118371_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113392","article-title":"Monoterpenoid indole alkaloid dimers from Kopsia arborea inhibit cyclin-dependent kinase 5 and tau phosphorylation","volume":"203","author":"Chen","year":"2022","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib83","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1021\/acs.jnatprod.5b00681","article-title":"Galanthamine, plicamine, and secoplicamine alkaloids from zephyranthes candida and their anti-acetylcholinesterase and anti-inflammatory activities","volume":"79","author":"Zhan","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118371_bib84","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.phytochem.2013.10.002","article-title":"Monoterpene indole alkaloids from the stem bark of Mitragyna diversifolia and their acetylcholine esterase inhibitory effects","volume":"96","author":"Cao","year":"2013","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113473","article-title":"Alkaloids with cholinesterase inhibitory activities from the bulbs of crinum \u00d7 amabile donn ex ker gawl","volume":"205","author":"Chaichompoo","year":"2023","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib86","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1021\/np400978x","article-title":"Alkaloids from the roots of Stichoneuron caudatum and their acetylcholinesterase inhibitory activities","volume":"77","author":"Ramli","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118371_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2020.112566","article-title":"Voacafrines A-N, aspidosperma-type monoterpenoid indole alkaloids from Voacanga africana with AChE inhibitory activity","volume":"181","author":"Zhao","year":"2021","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2023.113929","article-title":"Amaryllidaceae alkaloids from the bulbs of Crinum latifolium L. and their cholinesterase inhibitory activities","volume":"217","author":"Chaichompoo","year":"2024","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib89","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.fitote.2015.05.019","article-title":"Proaporphine and aporphine alkaloids with acetylcholinesterase inhibitory activity from stephania epigaea","volume":"104","author":"Dong","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2025.118371_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104408","article-title":"New acetylcholinesterase inhibitors isolated from Delphinium uncinatum","volume":"16","author":"Gul","year":"2023","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib91","series-title":"Chem. Proc.","first-page":"102","article-title":"Acetylcholinesterase as a target for heliotridine-type alkaloids isolated from plants: a computational study","author":"Defant","year":"2024"},{"key":"10.1016\/j.ejmech.2025.118371_bib92","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1159\/000438560","article-title":"New indole alkaloids from the bark of Rauvolfia reflexa and their cholinesterase inhibitory activity","volume":"37","author":"Fadaeinasab","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2025.118371_bib93","doi-asserted-by":"crossref","first-page":"527","DOI":"10.35588\/blacpma.19.18.5.35","article-title":"Aporphine alkaloids from Piper erecticaule and acetylcholinesterase inhibitory activity","volume":"18","author":"Salleh","year":"2019","journal-title":"Bol. Latinoam. y Del Caribe Plantas Med. y Aromat."},{"key":"10.1016\/j.ejmech.2025.118371_bib94","doi-asserted-by":"crossref","first-page":"304","DOI":"10.20307\/nps.2024.30.4.304","article-title":"Alkaloids with acetylcholinesterase inhibitory activities from Crinum latifolium L","volume":"30","author":"Trang","year":"2024","journal-title":"Nat. Prod. Sci."},{"key":"10.1016\/j.ejmech.2025.118371_bib95","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1080\/14786419.2018.1560287","article-title":"12\u03b1-hydroxy- N -demethyl-sauroxine, a lycodane type alkaloid from phlegmariurus saururus","volume":"34","author":"Vallejo","year":"2020","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2025.118371_bib96","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1080\/14786419.2020.1739040","article-title":"Two new amide alkaloids from Portulaca oleracea L. and their anticholinesterase activities","volume":"35","author":"Xu","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2025.118371_bib97","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1080\/14786419.2014.989847","article-title":"Geissoschizine methyl ether N -oxide, a new alkaloid with antiacetylcholinesterase activity from Uncaria rhynchophylla","volume":"29","author":"Jiang","year":"2015","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2025.118371_bib98","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1080\/14786419.2019.1696796","article-title":"Alkaloids with acetylcholinesterase inhibitory activity from Corydalis racemosa (thunb.) pers","volume":"35","author":"Yao","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2025.118371_bib99","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1080\/14786419.2018.1460833","article-title":"A new alkaloid from Portulaca oleracea L. and its antiacetylcholinesterase activity","volume":"33","author":"Xiu","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2025.118371_bib100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.phytochem.2012.11.015","article-title":"Indole alkaloids of psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors","volume":"86","author":"Passos","year":"2013","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib101","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bioorg.2018.01.038","article-title":"Cholinesterase inhibitory alkaloids from the rhizomes of Coptis chinensis","volume":"77","author":"Cao","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib102","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejmech.2017.06.007","article-title":"Isosteroidal alkaloids as potent dual-binding site inhibitors of both acetylcholinesterase and butyrylcholinesterase from the bulbs of Fritillaria walujewii","volume":"137","author":"Liu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib103","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ejmech.2016.10.057","article-title":"Amaryllidaceae alkaloids with new framework types from zephyranthes candida as potent acetylcholinesterase inhibitors","volume":"127","author":"Zhan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib104","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmech.2017.05.019","article-title":"Discorhabdin alkaloids from antarctic latrunculia spp. sponges as a new class of cholinesterase inhibitors","volume":"136","author":"Boti\u0107","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2020.112450","article-title":"Monoterpene indole alkaloids with diverse skeletons from the stems of Rauvolfia vomitoria and their acetylcholinesterase inhibitory activities","volume":"177","author":"Zhan","year":"2020","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib106","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.phytochem.2018.09.001","article-title":"Three lycopodium alkaloids from Thai club mosses","volume":"156","author":"Nilsu","year":"2018","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.118371_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2025.120718","article-title":"Targeted discovery of anthranilic acid-based alkaloids with neuroprotective and acetylcholinesterase inhibitory effects from natural indigo plant (Persicaria tinctoria) using DeepSAT technology","volume":"226","author":"Yang","year":"2025","journal-title":"Ind. Crops Prod."},{"key":"10.1016\/j.ejmech.2025.118371_bib108","article-title":"Bioactive aporphine alkaloids from the roots of Artabotrys spinosus : cholinesterase inhibitory activity and molecular docking studies","volume":"13","author":"Sichaem","year":"2018","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ejmech.2025.118371_bib109","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.fct.2017.05.009","article-title":"Inhibition on cholinesterase and tyrosinase by alkaloids and phenolics from Aristotelia chilensis leaves","volume":"109","author":"Cespedes","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2025.118371_bib110","article-title":"Anti-acetylcholinesterase alkaloids from Annona glabra leaf","volume":"10","author":"Lee","year":"2015","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ejmech.2025.118371_bib111","article-title":"Vasicinone, a pyrroloquinazoline alkaloid from adhatoda vasica nees enhances memory and cognition by inhibiting cholinesterases in Alzheimer's disease","volume":"3","author":"Bhanukiran","year":"2023","journal-title":"Phytomed. Plus"},{"key":"10.1016\/j.ejmech.2025.118371_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104136","article-title":"Monoterpene indole alkaloids with acetylcholinesterase inhibitory activity from the leaves of Rauvolfia vomitoria","volume":"102","author":"Zhan","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107525","article-title":"Pseudo-natural products: expanding chemical and biological space by surpassing natural constraints","volume":"150","author":"Ahamad","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117088","article-title":"Exploring the anticancer potential and mechanisms of action of natural coumarins and isocoumarins","volume":"282","author":"Aqib","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118371_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155972","article-title":"Coumarins as versatile therapeutic phytomolecules: a systematic review","author":"Hussain","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.118371_bib116","series-title":"Plant-Derived Bioact","first-page":"185","article-title":"Chromenes: phytomolecules with immense therapeutic potential","author":"Hussain","year":"2020"},{"key":"10.1016\/j.ejmech.2025.118371_bib117","series-title":"Plant-Derived Bioact","first-page":"375","article-title":"Anticancer and chemopreventive phytochemicals from cruciferous plants","author":"Idrees","year":"2020"},{"key":"10.1016\/j.ejmech.2025.118371_bib118","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/jacs.1c11270","article-title":"Chemical evolution of natural product structure","volume":"144","author":"Grigalunas","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118371_bib119","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1021\/acs.jcim.1c01084","article-title":"Pseudonatural products occur frequently in biologically relevant compounds","volume":"61","author":"Gally","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118371_bib120","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1039\/D0NP00015A","article-title":"Guided by evolution: from biology oriented synthesis to pseudo natural products","volume":"37","author":"Cremosnik","year":"2020","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2025.118371_bib121","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1021\/jm049782n","article-title":"Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues","volume":"47","author":"Bolognesi","year":"2004","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:58:01Z","timestamp":1780909081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":121,"alternative-id":["S0223523425011365"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118371","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural alkaloids with therapeutic potential against Alzheimer's disease through cholinesterase inhibition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118371"}}